Europe meeting, experts discussed the challenges and strategies of small and mid-sized biopharma companies surrounding ...

AstraZeneca plans to submit the positive data Breztri Aerosphere in asthma for to regulatory authorities for review.

BioCardia has announced the enrolment of the first subject in CardiAMP HF II trial of its cell therapy for treating heart ...

Pliant Therapeutics will cut 45% of its workforce in a sweeping restructuring effort aimed at extending its cash runway, the ...

Tempus AI has announced that it is using the TIME Network for Phase I trials to expedite site activation and enrolment.